Bioactive Restorative Dental Materials-The New Frontier.


Journal

Dental clinics of North America
ISSN: 1558-0512
Titre abrégé: Dent Clin North Am
Pays: United States
ID NLM: 0217440

Informations de publication

Date de publication:
10 2022
Historique:
entrez: 10 10 2022
pubmed: 11 10 2022
medline: 13 10 2022
Statut: ppublish

Résumé

Bioactive materials for dental resin restorations are a rising field of investigation exploring treatment strategies for reducing the recurrence of carious lesions. The current effort has been directed toward developing dental materials that can inhibit biofilms and prevent tooth mineral loss. Bioactive resin materials have shown the potential to interfere with polymicrobial consortia in vivo and help maintain the lifespan of restorations.

Identifiants

pubmed: 36216446
pii: S0011-8532(22)03457-7
doi: 10.1016/j.cden.2022.05.005
pii:
doi:

Substances chimiques

Composite Resins 0
Dental Materials 0

Types de publication

Journal Article Review Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

551-566

Subventions

Organisme : NIDCR NIH HHS
ID : R03 DE030562
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors have nothing to disclose.

Auteurs

Mary Anne S Melo (MAS)

Program in Dental Biomedical Sciences, University of Maryland School of Dentistry, 650 West Baltimore Street, Baltimore, MD 21201, USA; Division of Operative Dentistry, Department of General Dentistry, University of Maryland Dental School, 650 West Baltimore Street, Baltimore, MD 21201, USA. Electronic address: mmelo@umaryland.edu.

Lamia Mokeem (L)

Program in Dental Biomedical Sciences, University of Maryland School of Dentistry, 650 West Baltimore Street, Baltimore, MD 21201, USA.

Jirun Sun (J)

The Forsyth Institute, Harvard School of Dental Medicine Affiliate, 245 First Street, Cambridge, MA 02142, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH